1-3 of 3
Jaya Sharma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Proteasome Inhibitor, Ixazomib, Combined with Novel Drug Combinations in T-Cell Lymphoma (TCL) and Hodgkin Lymphoma (HL): Identification of Key Genes and Signaling Pathways Via a Novel Systems Biology Approach

Frank C. Passero, Jr., MD, Ravi Dashnamoorthy, PhD, Afshin Beheshti, PhD, Lynn Hlatky, PhD, Nassera Abermil, MS, PharmD, Michael E Coyle, MD, Jaya Sharma, MD MBBS, Andrew M. Evens, DO, MSc
Journal: Blood
Blood (2015) 126 (23): 2753.
https://doi.org/10.1182/blood.V126.23.2753.2753
Published: 2015
Journal Articles

Lenalidomide in non-Hodgkin lymphoma: biological perspectives and therapeutic opportunities

Clinical Trials & Observations
Athena Kritharis, Michael Coyle, Jaya Sharma, Andrew M. Evens
Journal: Blood
Blood (2015) 125 (16): 2471–2476.
https://doi.org/10.1182/blood-2014-11-567792
Published: 2015
Includes: Supplemental data
Journal Articles

Genome-Wide Analysis Reveals MYC-Dependent Cell Death and Identifies Predictive Biomarkers of Ixazomib Sensitivity in Preclinical Models of T-Cell Lymphoma (TCL) and Hodgkin Lymphoma (HL)

Ravi Dashnamoorthy, PhD, Afshin Behesti, PhD, Nassera Abermil, MS, PharmD, Jaya Sharma, MD MBBS, Michael Coyle, Irawati Kandela, PhD, Andrew Mazar, PhD, Lynn Hlatky, PhD, Andrew M. Evens, DO, MSc
Journal: Blood
Blood (2014) 124 (21): 3120.
https://doi.org/10.1182/blood.V124.21.3120.3120
Published: 2014